Subhashini Bolisetty retweeted
Congratulations @DrKeeksPhD!
Meet Kelly Hyndman, Ph.D., associate professor in the @UABDeptMed, and accomplished potter. Read more about Dr. Hyndman in the summer edition of the UAB Medicine Magazine.
uab.edu/medicine/news/medici…
Subhashini Bolisetty retweeted
Congratulations to that our Caroline Marshall Scholar, Alyssa Hill and her mentor Dr. Subhashini Bolisetty @BolisettySu for completing the summer program with a presentation at the CORD summer science program.
@DrTimmyLee1
Subhashini Bolisetty retweeted
This month, @DanaRizk1 begins her term as president of the #SSCI, where she will work to advance medical research, encourage trainees to enter academic medicine, and support junior faculty success in clinical investigation.
👏 Kudos, Dr. Rizk! @UAB_NRTC
Subhashini Bolisetty retweeted
2025 UAB Renal Symposium is scheduled for May 22 hybrid (KAUL 270 & zoom for outside UAB attendees)! Dr. David Pollock @davidpollock929 @UAB_NRTC will present the Schafer Lecture! uab.edu/medicine/obriencente……
@UABCDIB @UAB_NRTC @DrPaulKidney @ogutierrez13
@yoderlab_uab
Subhashini Bolisetty retweeted
Replying to @nkf
Subhashini Bolisetty retweeted
Congratulations Dr. Timmy Lee @DrTimmyLee1 !!!
Dr. Timmy Lee will serve as the next division director for the UAB Division of Nephrology @UAB_NRTC, effective July 1, 2025.
@ogutierrez136
Subhashini Bolisetty retweeted
Proud to serve as the Honorary Chair for this year’s #KidneyWalk. Grateful to everyone who walked, donated, and supported this cause. Thanks to your generosity, we have exceeded our fundraising goal—making a real impact on kidney patients and their families. @ALKidneyFound
Subhashini Bolisetty retweeted
Congratulations to Dr. Van Huynh on successfully defending her dissertation! 🎉👏
Her research on The Role of Aquaporin-3 Lysine 282 Acetylation in Renal Water Balance is a remarkable contribution to kidney research. Wishing her continued success in her scientific journey! 🧪🔬
Subhashini Bolisetty retweeted
#WhyScience Today, I am launching a 100-day Twitter/X campaign highlighting the importance of science, academia, and academic research in the U.S., with one tweet per day. Please help to increase visibility by liking, retweeting and adding to it.
Subhashini Bolisetty retweeted
Congratulations Dr. Rizk @DanaRizk1 @UAB_NRTC ! 👏👏Dana Rizk, M.D., has been appointed associate dean for Clinical Trials. Alongside Dr. Joiner, she will lead the HSOM's efforts to advance clinical trials.
uab.edu/medicine/news/latest…
Subhashini Bolisetty retweeted
Wonderful Andreoli Lecture and visit by Dr. Joseph Bonventre @BWHKidney. We learned a lot. Such a great role model for our trainees and fellows!
Subhashini Bolisetty retweeted
🩺Clash of the Kidneys: Rise of the Nephrons! 🩺
Vote today for your favorite SciArt! 🖌️
ow.ly/5OlT50Uk8uC
DEADLINE: Dec. 16, 2024
Celebrate the fusion of science and art by supporting the work that inspires you.
#AJPRenal #SciArt
Subhashini Bolisetty retweeted
🔬 Dr. @DanaRizk1 reported in the @NEJM that using iptacopan to treat patients with IgA nephropathy—a frequent cause of kidney failure—led to a significant reduction in proteinuria compared to the placebo group.
👏 Kudos to Dr. Rizk and her team! @UABNRTC
Subhashini Bolisetty retweeted
Thank you Dr. Tanjala S. Purnell @tpurnell1908 for visiting UAB and presenting the 2024 Denyse Thornley-Brown lecture @UAB_NRTC
@BeckerPhD @Carmendemigue12 @DrPaulKidney @ogutierrez136
Subhashini Bolisetty retweeted
Great work by UAB trainees at ASN Kidney Week; fascinating case presentations and I learned a lot. Many thanks to their mentors especially @Nephronpower! @UAB_NRTC @KUHPRIME
Subhashini Bolisetty retweeted
Help increase understanding of cardiovascular kidney metabolic syndrome in women. Apply to the new network for funding.
Pre-proposals due by Oct. 30.
Subhashini Bolisetty retweeted
Wondering how #UABHeersink stays competitive in the current research landscape? Watch this video featuring @anupamuab, M.D., Dean of the UAB Heersink School of Medicine!
Subhashini Bolisetty retweeted
The 3rd Acute Kidney Injury: Bench to Bedside conference is coming May4-7,2025! Save the date! Great program plus an awesome Workforce development program for trainees! Travel awards, lots of great science and networking in beautiful Leesburg Virginia👇
Subhashini Bolisetty retweeted
🎞️First Author Highlight Article🎞️
Myeloid-specific ferritin light chain deletion does not exacerbate #sepsis-associated #AKI
By: James D. Odum, et al.
🔓ow.ly/5n2350SJuoR
#AJPRenal #Ferritin @UAB_NRTC @BolisettySu
Subhashini Bolisetty retweeted
The synthetic tetra-peptide SS-31 shows promise in alleviating mitochondrial dysfunction linked to common diseases. This study identified PLSCR3 as the essential biological target that facilitates the mitoprotective effects of SS-31 in vitro & in vivo bit.ly/JASN0338










































